Related Experiment Video
Updated: Oct 16, 2025

Visualization of SARS-CoV-2 using Immuno RNA-Fluorescence In Situ Hybridization
Published on: December 23, 2020
Molecular Insights on the Possible Role of Annexin A2 in COVID-19 Pathogenesis and Post-Infection Complications
Prakash Patil1, Praveenkumar Shetty1,2, Nithin Kuriakose3
1Central Research Laboratory, KS Hegde Medical Academy (KSHEMA), NITTE (Deemed to be University), Mangalore 575018, India.
Abstract:
Severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) has infected >235 million people and killed over 4.8 million individuals worldwide. Although vaccines have been developed for prophylactic management, there are no clinically proven antivirals to treat the viral infection. Continuous efforts are being made all over the world to develop effective drugs but these are being delayed by periodic outbreak of mutated SARS-CoV-2 and a lack of knowledge of molecular mechanisms underlying viral pathogenesis and post-infection complications. In this regard, the involvement of Annexin A2 (AnxA2), a lipid-raft related phospholipid-binding protein, in SARS-CoV-2 attachment, internalization, and replication has been discussed. In addition to the evidence from published literature, we have performed in silico docking of viral spike glycoprotein and RNA-dependent RNA polymerase with human AnxA2 to find the molecular interactions. Overall, this review provides the molecular insights into a potential role of AnxA2 in the SARS-CoV-2 pathogenesis and post-infection complications, especially thrombosis, cytokine storm, and insulin resistance.
Insights
Annexin A2 (AnxA2) plays a role in SARS-CoV-2 infection, impacting viral entry and replication. Understanding AnxA2's molecular interactions may reveal new antiviral targets for COVID-19 treatment.
Area of Science:
- Virology
- Molecular Biology
- Biochemistry
Background:
- Severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) has caused a global pandemic, with limited antiviral treatments available.
- Understanding the molecular mechanisms of viral pathogenesis and post-infection complications is crucial for developing effective therapies.
Purpose of the Study:
- To investigate the potential role of Annexin A2 (AnxA2) in SARS-CoV-2 infection.
- To explore the molecular interactions between AnxA2 and SARS-CoV-2 components.
- To provide insights into AnxA2's involvement in COVID-19 pathogenesis and complications.
Main Methods:
- Literature review on AnxA2 involvement in viral infections.
- In silico molecular docking of SARS-CoV-2 spike glycoprotein and RNA-dependent RNA polymerase with human AnxA2.
Main Results:
- AnxA2, a phospholipid-binding protein, is implicated in SARS-CoV-2 attachment, internalization, and replication.
- In silico docking revealed molecular interactions between viral proteins and AnxA2.
- AnxA2 may contribute to SARS-CoV-2 pathogenesis and post-infection issues like thrombosis and cytokine storm.
Conclusions:
- AnxA2 is a potential key player in SARS-CoV-2 pathogenesis.
- Targeting AnxA2 interactions could offer novel therapeutic strategies against COVID-19.
- Further research into AnxA2's role in complications like thrombosis and insulin resistance is warranted.
More Related Videos
06:32Author Spotlight: Exploring Plasma Membrane Repair Mechanisms with Innovative Thermoplasmonic Puncturing
Published on: January 19, 2024
07:56Monitoring Changes in Human Umbilical Vein Endothelial Cells upon Viral Infection Using Impedance-Based Real-Time Cell Analysis
Published on: May 5, 2023
Related Concept Videos
Leaky Scanning
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Intracellular Signaling Affects Focal Adhesions
Some...
Pneumonia II: Pathophysiology
Adherens Junctions
Adherens Junctions are Dynamic
Acute Pancreatitis II: Clinical Manifestations and Management